Strategic Leap in Chemicals: Anupam Rasayan Acquires Jayhawk Fine Chemicals for $150 Million

The acquisition includes Jayhawk’s equity value and existing loans payable to exiting shareholders. Anupam Rasayan will finance the transaction through a mix of internal accruals, debt, and quasi equity from a global investment management firm with assets exceeding $100 billion. Jayhawk, part of the CABB Group, has steadily grown revenues since 2018 and is known for its specialty chemical expertise in industrial and life sciences applications. The acquisition is expected to be earnings accretive, enhancing Anupam’s global competitiveness and diversifying its portfolio. With this move, Anupam Rasayan positions itself as a significant player in the U.S. market, aligning with its long-term strategy of expanding into high-margin specialty segments.  

• Acquisition valued at $150 million, covering equity and loans  
• Jayhawk Fine Chemicals brings U.S. manufacturing presence to Anupam Rasayan  
• Financing through internal accruals, debt, and quasi equity from a global investment firm  
• Deal expected to be EPS accretive and strategically transformative  
• Marks Anupam’s entry into high-value U.S. specialty chemical markets  

The acquisition of Jayhawk Fine Chemicals represents a pivotal milestone for Anupam Rasayan, enabling global expansion, strengthening its specialty portfolio, and positioning the company as a competitive force in both Indian and international chemical markets.  

Sources: The Hindu BusinessLine, The Hindu, CNBC TV18, CABB Group Press Release